Announcements Trials
Browse Landscape

Phase

Phase 1 6

Status

Completed 3Terminated 2Unknown 1

Sponsor Class

INDUSTRY 6OTHER 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Other solid neoplasm 6

Conditions

Neoplasms 2875Carcinoma, Non-Small-Cell Lung 2428Breast Neoplasms 2068Colorectal Neoplasms 1247Neoplasm Metastasis 1232Prostatic Neoplasms 1080Melanoma 974Multiple Myeloma 963Ovarian Neoplasms 904Recurrence 852Leukemia, Myeloid, Acute 810Lung Neoplasms 758Pancreatic Neoplasms 753Lymphoma, Non-Hodgkin 727Lymphoma 660Stomach Neoplasms 623Carcinoma, Hepatocellular 566Carcinoma, Renal Cell 546Squamous Cell Carcinoma of Head and Neck 529Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 451Glioblastoma 436Advanced Solid Tumors 432Small Cell Lung Carcinoma 411Triple Negative Breast Neoplasms 410Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 369Advanced Solid Tumor 351

Interventions

capivasertib 1atezolizumab 1N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide 1N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 1Midazolam 1Itraconazole 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Solid Tumour × Clear all
NCT06488716 2025-12-24

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Genentech, Inc.

Phase 1 Terminated
12 enrolled
Other solid neoplasm

Solid Tumour

NCT04958226 2024-01-25

A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

AstraZeneca

Phase 1 Completed
21 enrolled
Other solid neoplasm

Solid Tumour

NCT04121910 2020-01-23

A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole

AstraZeneca

Phase 1 Completed
16 enrolled
Other solid neoplasm

Solid Tumour

NCT01516645 2017-03-16

Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors

Kyowa Kirin Co., Ltd.

Phase 1 Terminated
14 enrolled
Other solid neoplasm

Solid Tumour

NCT01226407 2012-12-31

Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile

CrystalGenomics, Inc.

Phase 1 Unknown
36 enrolled
Other solid neoplasm

Solid Tumour

NCT01300468 2011-02-21

Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors

Nerviano Medical Sciences

Phase 1 Completed
38 enrolled
Other solid neoplasm

Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡